Xiaonian Zhu

3.0k total citations
65 papers, 633 citations indexed

About

Xiaonian Zhu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaonian Zhu has authored 65 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Xiaonian Zhu's work include Chemokine receptors and signaling (10 papers), RNA modifications and cancer (10 papers) and Cancer-related gene regulation (9 papers). Xiaonian Zhu is often cited by papers focused on Chemokine receptors and signaling (10 papers), RNA modifications and cancer (10 papers) and Cancer-related gene regulation (9 papers). Xiaonian Zhu collaborates with scholars based in China, United States and Taiwan. Xiaonian Zhu's co-authors include Shengkui Tan, Chunhua Bei, Chao Tan, Linyuan Qin, Wenxiang Shi, Ren Yuan, Shidong Zhang, Zhini He, Zhengbao Zhang and Yonghua He and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Xiaonian Zhu

53 papers receiving 627 citations

Peers

Xiaonian Zhu
Xi Huang China
Nina E. Landvik Norway
Cheng Su China
Paul Severson United States
Kelie Chen China
Monica Cipollini Italy
Sheng‐Kai Hsu Taiwan
Zhigang Zhuang China
Lixuan Wei China
Xi Huang China
Xiaonian Zhu
Citations per year, relative to Xiaonian Zhu Xiaonian Zhu (= 1×) peers Xi Huang

Countries citing papers authored by Xiaonian Zhu

Since Specialization
Citations

This map shows the geographic impact of Xiaonian Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonian Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonian Zhu more than expected).

Fields of papers citing papers by Xiaonian Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaonian Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonian Zhu. The network helps show where Xiaonian Zhu may publish in the future.

Co-authorship network of co-authors of Xiaonian Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaonian Zhu. A scholar is included among the top collaborators of Xiaonian Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaonian Zhu. Xiaonian Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Xiaonian, et al.. (2025). BioGraphFusion: graph knowledge embedding for biological completion and reasoning. Bioinformatics. 41(7).
2.
3.
Huang, Yuanyuan, Yue Tang, Li Xu, et al.. (2025). Dihydroartemisinin alleviates diethylnitrosamine-induced hepatocarcinogenesis by targeting a novel MAZ/TRIM50 axis. International Immunopharmacology. 156. 114733–114733.
4.
5.
Zhang, Rongcheng, Zhongqi Zhang, Di Li, et al.. (2024). REXO2 up-regulation is positively correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. International Immunopharmacology. 130. 111740–111740. 4 indexed citations
6.
Li, Di, et al.. (2024). Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 2493–2504. 3 indexed citations
7.
Zhang, Zhongqi, et al.. (2024). Predicting colorectal cancer risk: a novel approach using anemia and blood test markers. Frontiers in Oncology. 14. 1347058–1347058. 5 indexed citations
8.
Wu, Hongmei, Shidong Zhang, Run Tian, et al.. (2023). Myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary Thyroid Cancer. Frontiers in Bioscience-Landmark. 28(8). 162–162. 7 indexed citations
9.
Zhu, Xiaonian, et al.. (2022). Hb New York, preliminary results concerning the hematologic characteristics and the effects on thalassemia. Molecular Biology Reports. 49(7). 6199–6205. 1 indexed citations
10.
Zhang, Shidong, Di Li, Chunhua Bei, et al.. (2020). Clinical Significance of POM121 Expression in Lung Cancer. Genetic Testing and Molecular Biomarkers. 24(12). 819–824. 5 indexed citations
11.
Tian, Run, Shidong Zhang, Chunhua Bei, et al.. (2020). M6A Demethylase FTO Plays a Tumor Suppressor Role in Thyroid Cancer. DNA and Cell Biology. 39(12). 2184–2193. 28 indexed citations
12.
Zhu, Xiaonian, Shidong Zhang, Shengkui Tan, et al.. (2020). Expression of CMTM4 shows clinical significance in lung cancer. Translational Cancer Research. 9(10). 6214–6220. 5 indexed citations
13.
Sun, Yi, Yonghua He, Lin Yang, et al.. (2020). Manganese induced nervous injury by α-synuclein accumulation via ATP-sensitive K(+) channels and GABA receptors. Toxicology Letters. 332. 164–170. 16 indexed citations
14.
Zhu, Xiaonian, Cong Li, Wen Zeng, et al.. (2019). Downregulated Expression of Chromobox Homolog 7 in Hepatocellular Carcinoma. Genetic Testing and Molecular Biomarkers. 23(5). 348–352. 9 indexed citations
15.
Zhu, Xiaonian, Zhigang Wang, Xiaoqiang Qiu, et al.. (2018). Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population. DNA and Cell Biology. 37(7). 634–641. 17 indexed citations
16.
Zhu, Xiaonian, Cong Li, Chunhua Bei, et al.. (2018). Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma. DNA and Cell Biology. 38(2). 193–197. 43 indexed citations
17.
Bei, Chunhua, Ying Zhang, Xiaonian Zhu, et al.. (2017). Clinical significance of CMTM4 expression in hepatocellular carcinoma. OncoTargets and Therapy. Volume 10. 5439–5443. 26 indexed citations
18.
Zhu, Xiaonian, Daochuan Li, Zhengbao Zhang, et al.. (2016). Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen‐induced cell transformation. Molecular Carcinogenesis. 56(5). 1449–1460. 14 indexed citations
19.
Zhu, Xiaonian, Meng Yan, Wei Luo, et al.. (2016). Expression and clinical significance of PcG-associated protein RYBP in hepatocellular carcinoma. Oncology Letters. 13(1). 141–150. 10 indexed citations
20.
Zhu, Xiaonian, Liping Chen, Qing Bai, et al.. (2014). PP2A–AMPKα–HSF1 axis regulates the metal-inducible expression of HSPs and ROS clearance. Cellular Signalling. 26(4). 825–832. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi Huang Breakdown of academic impact, for papers by Nina E. Landvik Breakdown of academic impact, for papers by Cheng Su Breakdown of academic impact, for papers by Paul Severson Breakdown of academic impact, for papers by Kelie Chen Breakdown of academic impact, for papers by Monica Cipollini Breakdown of academic impact, for papers by Sheng‐Kai Hsu Breakdown of academic impact, for papers by Zhigang Zhuang Breakdown of academic impact, for papers by Lixuan Wei
Rankless by CCL
2026